A four segment trial-repeat model is developed to model sales of a fre
quently purchased product in the early stage of the product's life cyc
le. The model can be calibrated using aggregate data alone. Two versio
ns of the model, one emphasizing the competitive aspect of marketing c
ommunications and another emphasizing the informative aspect, are esti
mated from data on 21 newly launched pharmaceutical products. The mode
l provides valuable diagnostics such as an early estimate of the long-
run market share of the new product, a decomposition of total sales (i
nto trial sales due to marketing activities, trial sales due to word-o
f-mouth, and repeat sales), the changing composition of the trial mark
et and repeat market over time, and the time when the trial market is
expected to be saturated. In addition, the effectiveness of the entran
t's marketing efforts, word-of-mouth communication, and buyers' trial
experience are analyzed with the model. A cross-sectional analysis bas
ed on the empirical estimation results of our model reveals interestin
g insights into product introduction strategies. We find that: 1) the
effectiveness of the firms' communication activities on trial is relat
ed mainly to product quality attributes and market growth whereas that
of word-of-mouth is associated with product class characteristics and
market competitiveness, and 2) the effect of product trial on repeat
purchases is related mainly to product quality attributes and various
market characteristics such as size, growth, competitiveness, and fami
liarity.